
Common Diabetes Treatment May Exacerbate the Disease, Study Finds
A new study warns that long-term use of sulphonylureas, common diabetes drugs, may impair insulin-producing beta cells by causing them to lose their functional identity, potentially accelerating the progression of type 2 diabetes. The research suggests that these drugs could contribute to the decline in treatment efficacy over time, but also highlights that loss of cell identity might be reversible, opening avenues for future therapies.





